Are thirty minutes of rest between two 6-Minute Walk Tests enough for cardiovascular and symptomatic recovery for patients with chronic obstructive pulmonary disease?
DOI:
https://doi.org/10.590/1809-2950/14319622032015Abstract
Two 6-Minute Walk Tests (6MWT) are required to evaluate functional capacity of exercise in patients with Chronic Obstructive Pulmonary Disease (COPD). Despite the fact that the American Thoracic Society (ATS) has proposed a one-hour interval between two tests, it is unknown whether a shorter period could be used for the normalization of physiological variables. We aimed to verify that an interval of 30 minutes of rest between two 6MWT is sufficient for cardiovascular and symptomatic variables to return to their basal levels. Two hundred and fifteen patients with COPD (121H, 66±8 years; FEV1: 44 [32-57]% predicted) performed two 6MWT with a thirty-minute interval between them. Before and after the tests, we measured Blood Pressure (BP), Heart Rate (HR), peripheral oxygen saturation (SpO2), degree of dyspnea, and fatigue. Patients walked the longest distance in the second test (6MWT1: 450 [390-500]m vs 6MWT2: 470 [403-515]m; p<0.0001). The initial HR was greater in the second 6MWT (initial HR 6MWT1: 83 [73-91]bpm vs 6MWT2: 83 [75-93]bpm; p=0.001). Dyspnea and fatigue were lower before the second test (initial Borg dyspnea 6MWT1: 0.5 [0-2]m vs 6MWT2: 0 [0-2]; p = 0.0006 and initial Borg fatigue 6MWT1: 0 [0-2]m vs 6MWT2: 0 [0-2]; p = 0.007). There were no differences regarding the BP and the SpO2(p>;0.05 for all). Although there are statistically significant differences in initial HR between the first and second test, this finding does not seem to be clinically relevant. Therefore, thirty minutes of rest between two 6MWT are sufficient for cardiovascular and symptomatic recovery in patients with COPD.Downloads
References
Global strategy for Diagnosis, Management, and Prevention of
COPD: revised 2014. Global Initiative for Chronic Obstructive
Lung Disease Disponível em <http://www.goldcopd.org/
uploads/users/files/GOLD_Report _2014_Jun11.pdf> Acesso
em: 15 julho 2014.
Hernandes NA, Teixeira DC, Probst VS, Brunetto AF, Ramo
EMC, Pitta F. Perfil do nível de atividade física na vida diária
de pacientes portadores de DPOC no Brasil. J Bras Pneumol.
;35(10):949-56.
Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG,
Gosselink R, et al. Recommendations on the use of exercise
testing in clinical practice. Eur Respir J 2007; 29: 185-209.
American Thoracic Society/American College of Chest
Physicians. Statement on Cardiopulmonary Exercise Testing.
Am J Respir Crit Care Med. 2003;167:211-77.
ATS Committee on Proficiency Standards for Clinical
Pulmonary Function Laboratories. ATS statement: guidelines
for the six-minute walk test. Am J Respir Crit Care Med.
;166(1):111-7.
Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins
S. Six minute walk distance in healthy subjects aged 55–75
years. Respir Med. 2006;100:658-56.
Hernandes NA, Wouters EFM, Meijer K, Annegarn J, Pitta
F, Spruit MA. Reproducibility of 6-minute walking test in
patients with COPD. Eur Respir J. 2011;38: 261-7.
Pereira CAC, Sato T, Rodrigues SC. New reference values for
forced spirometry in white adults in Brazil. J Bras Pneumol.
;33:397-406.
Borg GA. Psychophysical bases of perceived exertion. Med
Sci Sports Exerc. 1982;14:377-81.
Britto RR, Probst VS, Andrade AFD, Samora GAR, Hernandes
NA, Marinho PEM, et al. Reference equations for the sixminute walk distance based on a Brazilian multicenter study.
Braz J Phys Ther. 2013;17(6):556-63.
Tanaka H, Monahan KD, Seals DR. Age-predicted maximal
heart rate revisited. J Am Coll Cardiol. 2001:37(1):153-6.
Brawner CA, Ehrman JK, Schairer JR, Cao JJ, Keteyian
SJ. Predicting maximum heart rate among patients with
coronary heart disease receiving β-adrenergic blockade
therapy. Am Heart J. 2004;148(5):910-4.
Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D,
Slivka W et al. “Six-Minute Walk Distance in Chronic
Obstructive Pulmonary Disease”. Am J Respir Crit Care Med.
;167(11):1522-7.
Lacasse M, Maltais F, Poirier P, Lacasse Y, Marquis K, Jobin J, et
al. Post-exercise heart rate recovery and mortality in chronic
obstructive pulmonary disease. Respir Med. 2005;99, 877-86.
Zhang J. Effect of age and sex on heart rate variability in healthy
subjects. J Manipulative Physiol Ther. 2007;30(5):374-9.
Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y.
The rate-pressure product as an index of myocardial oxygen
consumption during exercise in patients with angina pectoris.
Circulation. 1978;57(3):549-56
Ribeiro LRG, Mesquita RB, Vidotto LS, Merli MF, Carvalho DR,
Castro LA. Are 30 minutes of rest between two incremental
shuttle walking tests enough for cardiovascular variables
and perceived exertion to return to baseline values? Braz J
Phys Ther 2015 Jan-Feb;19(1):61-9
Cooper CB. Desensitization to dyspnea in COPD with specifi
city for exercise training mode. Int J COPD. 2009;4:33-43.
Belman MJ, Brooks LR, Ross DJ, Mohsenifar Z. Variability
of breathlessness measurement in patients with Chronic
Obstructive Pulmonary Disease. Chest 1991; 99:566-71.
Brooks D, Solway S, Weinacht K, Wang D. Comparison
between an indoor and an outdoor 6-minute walk test
among individuals with chronic obstructive pulmonary
disease. Arch Phys Med Rehabil. 200;84(6):873-6.
Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V,
Saey D, et al. An Official European Respiratory Society
/ American Thoracic Society Technical Standard: Field
Walking Tests in Chronic Respiratory Disease. Eur Respir J.
;44(6):1428-46
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Fisioterapia e Pesquisa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
